SOLVAY Stock: Down 2.7% at Close on Monday, -8.92% Over the Past Week
Belgian chemical company Solvay closed lower this Monday. The stock fell by 2.7%, dropping to 25.94 euros after a previous close at 26.66 euros. This daily decline is part of a more concerning short-term trend, with the stock losing over 8% in just one week amid ongoing pressures.
At the end of the session, Solvay settled at 25.94 euros, down 2.7% compared to the previous close. Liquidity remains low: capital turnover reached only 0.52%, indicating moderate activity on the stock. Cumulative performance outlines a significantly deteriorated profile across all timeframes. Over seven days, the decline peaks at 8.92%. Over three months, the drop is 5.67%. Over twelve months, the stock has fallen by 30.34%, creating a substantial gap compared to the broader index: the CAC 40 has gained 9.46% over the same period. This divergence highlights a specific vulnerability of the stock to the current macroeconomic environment, with the basic materials sector facing enduring headwinds.
Technical Outlook
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
You're in — subscription confirmed!
Your first edition is on its way. Check your spam folder and add us to your contacts.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
Gratuit · chaque matin
Ne ratez plus rien sur vos actions
La tendance derrière les cours. L'essentiel des valeurs Euronext en quelques minutes.
📈les valeurs en mouvement, sur la durée
🎯les objectifs d'analystes qui évoluent
📰les actualités qui font bouger les cours
tendance · 6 séances
✓ C'est fait, vous êtes inscrit !
Votre première édition arrive bientôt. Pensez à vérifier vos spams.
Une erreur est survenue.
CAC 40 · SBF 120 · données indicatives · aucun conseil en investissement · désinscription à tout moment.
Technically, the stock's configuration remains fragile. Solvay is decisively trading below its two main moving averages: the 50-day MA at 27.39 euros and the 200-day MA at 29.79 euros, the latter exerting structural downward pressure. The gap widens between the price and these benchmarks, signaling a downward momentum. The RSI is at 45, an intermediate zone without extreme signals. The MACD shows weakness with a line at -0.05, a signal line at 0.11, and a negative histogram of -0.16, confirming the bearish momentum. Geometrically, the major support is established at 26.24 euros, just 0.30 euro above the current price, suggesting immediate vulnerability. Resistance remains distant at 28.68 euros. The Bollinger Bands tightly enclose the stock: the lower threshold is positioned at 25.93 euros, nearly touching the current price, while the upper threshold peaks at 28.97 euros.
Challenging market environment, excluding potential recovery measures from Sadara, updated guidance reflects Middle East impact
Risks mentioned
Middle East conflict impact of approximately €-25 million on underlying EBITDA in Q3 2026
Continued shutdown of the Peroxide plant at the Sadara complex in Jubail, Saudi Arabia accounted for €-15 million in Q3 2026
Challenging market environment affecting Group performance in Q3 2026
Opportunities identified
Joint venture contractual framework includes mechanisms designed to recover lost profitability from Sadara shutdown
Group exploring all available avenues to mitigate financial impact of shutdown
Transformation program and focus on cash generation and cost savings targets
Outlook / guidance
Expected EBITDA: 730 millions d'euros
Management commentary: In light of these developments, Solvay has reviewed its full-year 2026 guidance. Excluding potential revenue or recovery measures from Sadara for the remainder of 2026, the updated guidance is: Underlying EBITDA between €720 and €740 million
The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.
Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.